F1000Prime » Article Recommendations » Neurological Disorders »

Neuromuscular Diseases Recommendations

To view Article Recommendations, you must have an active subscription.

If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.

If you think you should be able to access this content, please contact us.

New to F1000? See this week’s top article below for a free preview of a Recommendation.

Take the tour.

SECTION HEADS

Daniel Drachman

Neuromuscular Laboratory, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA
Michael Hanna

UCL Institute of Neurology, University College London, London, UK

Section Topics

» Channelopathies
» Disorders of the neuromuscular junction: acquired autoimmune
» Disorders of the neuromuscular junction: acquired toxic
» Disorders of the neuromuscular junction: congenital myasthenic syndromes
» Electrodiagnostic testing
» Inflammatory myopathies
» Metabolic myopathies

» Motor neuropathies
» Muscular dystrophies
» Other inherited and congenital muscle disorders (e.g. Emery Dreifuss, oculopharyngeal, familial IBM)
» Therapy for neuromuscular diseases: gene therapy
» Therapy for neuromuscular diseases: immunomodulatory
» Therapy for neuromuscular diseases: other
» Toxic myopathies

LATEST RECOMMENDATION

There is a clear unmet need regarding treatments for multiple system atrophy (MSA). Mesenchymal stem cells (MSCs) are generally regarded as safe although, if injected intravenously, will accumulate in lung vessels. This study includes 33...

Christine Mummery, Leiden University Medical Center, Netherlands. F1000 Hematology

Dissent

INDIVIDUAL SUBSCRIPTIONS

Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.

Start your personal subscription today.

Subscribe for $9.95/month

Take the tour.